Other
Finite-Lived Intangible Assets, Accumulated Amortization
Boston Scientific Finite-Lived Intangible Assets, Accumulated Amortization increased by 2.1% to $11.23B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.7%, from $10.52B to $11.23B. Over 4 years (FY 2020 to FY 2024), Finite-Lived Intangible Assets, Accumulated Amortization shows an upward trend with a 7.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID:
other_finite_lived_intangible_assets_accumulated_amortizationHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.15B | $8.29B | $8.48B | $8.66B | $8.84B | $8.98B | $9.17B | $9.36B | $9.57B | $9.77B | $9.99B | $10.20B | $10.31B | $10.52B | $10.60B | $10.82B | $11.00B | $11.23B |
| QoQ Change | — | +1.7% | +2.2% | +2.2% | +2.1% | +1.6% | +2.2% | +2.0% | +2.3% | +2.1% | +2.2% | +2.1% | +1.1% | +2.1% | +0.7% | +2.1% | +1.7% | +2.1% |
| YoY Change | — | — | — | — | +8.4% | +8.3% | +8.2% | +8.1% | +8.3% | +8.9% | +8.9% | +9.0% | +7.7% | +7.7% | +6.1% | +6.1% | +6.7% | +6.7% |
Range$8.15B – $11.23B
CAGR+7.8%
Avg YoY Growth+7.8%
Median YoY Growth+8.1%
Current Streak17+ quarters growth
Finite-Lived Intangible Assets, Accumulated Amortization at Other Companies
Frequently Asked Questions
- What is Boston Scientific's finite-lived intangible assets, accumulated amortization?
- Boston Scientific (BSX) reported finite-lived intangible assets, accumulated amortization of $11.23B in Q3 2025.
- How has Boston Scientific's finite-lived intangible assets, accumulated amortization changed year-over-year?
- Boston Scientific's finite-lived intangible assets, accumulated amortization increased by 6.7% year-over-year, from $10.52B to $11.23B.
- What is the long-term trend for Boston Scientific's finite-lived intangible assets, accumulated amortization?
- Over 4 years (2020 to 2024), Boston Scientific's finite-lived intangible assets, accumulated amortization has grown at a 7.9% compound annual growth rate (CAGR), from $7.81B to $10.60B.